Single-Use Manufacturing Systems for Peptides: Industry Adoption

What Are Single-Use Manufacturing Systems?

Single-use manufacturing systems are equipment designed to be used once and then thrown away. They replace traditional stainless steel equipment that must be cleaned and sterilized between batches.

In the peptide world, these systems include disposable bioreactors, tubing, filters, bags, and mixers. They are made from specially tested plastics and polymers.

The concept is simple but powerful. Instead of spending hours cleaning equipment, you just swap in a new set and start the next batch right away.

According to Research and Markets, the global single-use bioprocessing market reached over $28 billion in 2025 and is expected to grow at a compound annual growth rate above 14% through 2030. This growth shows how fast the industry is adopting this technology.

Did you know? A single cleaning validation for traditional stainless steel equipment can take two to three days. Single-use systems eliminate this step entirely.

Why the Peptide Industry Is Embracing Disposable Bioprocessing

Disposable bioprocessing is a good fit for peptide manufacturing. Peptides are often made in smaller batches than traditional biologics.

Smaller batches mean the cost of cleaning large stainless steel systems does not make sense. Disposable systems match the scale much better.

Cross-contamination risk is also a big concern with peptides. Using fresh equipment for each batch removes this risk almost completely.

Speed matters too. Companies racing to bring new peptide drugs to market cannot afford long equipment turnaround times.

Key Components of Single-Use Peptide Manufacturing

Single-use peptide manufacturing involves several types of disposable equipment. Here is a look at the main components.

Component	Function	Material
Single-use bioreactors	Growing cells or running reactions	Polyethylene film bags
Disposable mixers	Blending solutions and buffers	Gamma-irradiated plastic
Single-use filters	Removing particles and contaminants	Membrane cartridges
Tubing assemblies	Connecting system components	Silicone or thermoplastic
Storage bags	Holding intermediates and products	Multi-layer polymer film
Sampling systems	Taking process samples safely	Pre-sterilized plastic units
Connectors	Joining disposable parts together	Aseptic single-use connectors

Each component is designed to meet strict pharmaceutical standards. They must be free from harmful chemicals that could leach into the product.

Benefits of Single-Use Systems in Pharma

The benefits of single-use systems pharma applications are well documented. Let us break down the main advantages.

Reduced contamination risk is the top benefit. Fresh equipment for every batch means no carryover from previous products.

Faster changeover saves valuable time. Swapping disposable parts takes minutes instead of the hours or days needed for cleaning.

Lower capital costs help smaller companies compete. You do not need to build expensive stainless steel facilities.

Greater flexibility lets companies switch between products easily. This is especially useful for contract manufacturers making multiple peptides.

Less water usage is good for the environment. Traditional cleaning uses thousands of liters of purified water per batch.

Benefit	Traditional Systems	Single-Use Systems
Setup time	8 to 24 hours	1 to 3 hours
Contamination risk	Moderate	Very low
Capital investment	$5M to $50M+	$500K to $5M
Water usage per batch	5,000 to 20,000 liters	Near zero
Flexibility	Low	Very high
Cleaning validation	Required every batch	Not needed

Expert Quote: "Single-use technology has fundamentally changed how we think about peptide manufacturing facility design. It is no longer a question of if companies should adopt it, but how quickly they can," says Dr. Robert Kline, a bioprocess engineering consultant.

How Single-Use Systems Work in Peptide Production

The process of using single-use systems in peptide production follows a clear workflow. Understanding this helps you see why it works so well.

First, the disposable components arrive pre-sterilized from the supplier. They are sealed in clean packaging and ready to use.

Technicians assemble the system by connecting bags, tubing, and filters. This is done in a controlled clean room environment.

Once assembled, the system is tested for integrity. Pressure tests and leak checks make sure everything is sealed properly.

The peptide synthesis or purification process then runs as normal. The only difference is that the equipment touching the product is brand new.

After the batch is complete, the disposable parts are removed. They are treated as pharmaceutical waste and disposed of properly.

The permanent equipment, like pumps and controllers, is wiped down. Then new disposable components are installed for the next batch.

Fact: Some peptide manufacturers report reducing their batch turnaround time by up to 70% after switching to single-use systems.

Challenges of Adopting Single-Use Peptide Manufacturing

Single-use peptide manufacturing is not without its challenges. Companies need to plan carefully before making the switch.

Waste generation is the biggest concern. All those disposable parts create a lot of plastic waste.

Extractables and leachables must be tested carefully. The plastic materials can sometimes release small amounts of chemicals into the product.

Supply chain dependence is another risk. If your disposable component supplier has a problem, your production stops.

Scale limitations exist for very large batches. Single-use bioreactors currently max out at around 2,000 to 6,000 liters.

Cost per batch can be higher for disposables. While capital costs are lower, the ongoing cost of buying new components adds up.

Challenge	Impact Level	Mitigation Strategy
Plastic waste	High	Recycling programs, bio-based plastics
Extractables/leachables	Medium	Thorough testing, qualified suppliers
Supply chain risk	Medium	Dual sourcing, safety stock
Scale limits	Medium	Multiple parallel units
Per-batch cost	Low to Medium	Volume purchasing agreements

Industry Adoption Rates and Trends

The adoption of single-use systems in the peptide industry has been accelerating. Several trends are driving this growth.

More than 85% of preclinical and clinical-stage biotech companies now use some form of single-use technology. This number has grown steadily over the past five years.

Contract development and manufacturing organizations, known as CDMOs, are leading the charge. They need the flexibility that disposable systems provide.

Hybrid approaches are also popular. Some companies use single-use for early-stage production and stainless steel for large-scale commercial manufacturing.

The COVID-19 pandemic also pushed adoption forward. Companies saw how quickly they could set up new production lines with disposable equipment.

If you are interested in how manufacturing trends affect hiring, check out our guide on peptide manufacturing workforce trends.

Environmental Considerations

The environmental impact of single-use systems is a hot topic. Critics point to the plastic waste generated by disposable equipment.

However, the full picture is more complex. Traditional systems use enormous amounts of water, energy, and cleaning chemicals.

Life cycle studies have shown that single-use systems often have a smaller overall carbon footprint. The water and energy savings can outweigh the plastic waste.

The industry is also working on solutions. Several companies are developing recycling programs for used single-use components.

Bio-based and biodegradable plastics are being tested as well. These could reduce the environmental impact even further in coming years.

Did you know? One lifecycle analysis found that single-use systems produce 50% less carbon dioxide than traditional stainless steel systems when water treatment and energy use are included in the calculation.

Regulatory Perspective on Disposable Bioprocessing

Regulators have been supportive of single-use technology. The FDA and EMA both accept processes that use disposable equipment.

However, companies must demonstrate that the disposable materials do not affect product quality. This means extensive testing for extractables and leachables.

Suppliers of single-use components must provide detailed documentation. This includes certificates of material composition and sterilization records.

Change control is especially important. If a supplier changes a material or design, the peptide manufacturer must evaluate the impact.

The regulatory framework continues to evolve. New guidance documents from regulatory agencies help standardize expectations for single-use systems.

Choosing the Right Single-Use System for Your Facility

Picking the right system takes careful evaluation. Not every single-use product works for every peptide manufacturing process.

Start by mapping your process requirements. What volumes do you need? What temperatures and pressures are involved?

Next, evaluate suppliers thoroughly. Look at their track record, quality systems, and ability to deliver on time.

Test the components before committing. Run trial batches to make sure the disposable parts perform as expected.

Consider the total cost of ownership. Include the price of disposables, waste disposal, storage space, and staff training.

Work with experienced consultants or staffing partners who understand peptide manufacturing. Our post on biotech facility staffing strategies explains how to find the right people for your facility.

The Future of Single-Use Systems in Peptide Manufacturing

The future of single-use peptide manufacturing looks promising. Several innovations are on the horizon.

Smarter sensors built into disposable components will provide real-time data. This will improve process monitoring and control.

Larger single-use bioreactors are being developed. Some companies are working on systems that can handle 10,000 liters or more.

Modular manufacturing pods are another trend. These are self-contained production units built entirely around single-use technology.

3D printing may eventually allow companies to make custom disposable parts on site. This could reduce supply chain dependence and cut costs.

Continuous manufacturing using single-use flow paths is also being explored. This could replace traditional batch processing for some peptide products.

Workforce Implications of Single-Use Technology

The shift to single-use systems changes what skills workers need. Companies must train their teams on new procedures and equipment.

Operators need to learn how to assemble and test disposable systems. Quality teams need to understand extractable and leachable testing.

Supply chain staff must manage a new category of critical materials. Inventory planning for disposable components requires different strategies than for permanent equipment.

Engineers need to design facilities that can accommodate single-use systems. This includes proper waste handling and storage areas.

The good news is that single-use systems are generally easier to operate. Newer workers can become productive more quickly than with traditional equipment.

Frequently Asked Questions

What is single-use peptide manufacturing?

Single-use peptide manufacturing uses disposable equipment components that are discarded after each production batch. This includes bags, tubing, filters, and bioreactors made from specially tested plastic materials.

Why are single-use systems becoming popular in pharma?

Single-use systems pharma adoption is growing because they reduce contamination risk, speed up production, lower capital costs, and offer more manufacturing flexibility compared to traditional stainless steel equipment.

How does disposable bioprocessing reduce contamination?

Disposable bioprocessing uses brand-new equipment for every batch. Since nothing is reused, there is no chance for product carryover or residue from previous batches to contaminate the next run.

Are single-use systems environmentally friendly?

While they generate plastic waste, life cycle studies show single-use systems often have a smaller overall environmental footprint. They save large amounts of water, energy, and cleaning chemicals compared to traditional systems.

What are the main challenges of single-use manufacturing?

The main challenges include plastic waste disposal, testing for extractables and leachables, supply chain dependence on component suppliers, and scale limitations for very large production volumes.

How much do single-use systems cost compared to traditional equipment?

Single-use systems have much lower upfront capital costs, often 80% to 90% less than building a stainless steel facility. However, the per-batch cost of disposable components can be higher than the cleaning costs for reusable equipment.

Can single-use systems handle large-scale peptide production?

Current single-use bioreactors can handle up to about 6,000 liters. For very large-scale production, companies may use multiple single-use systems in parallel or adopt a hybrid approach combining disposable and traditional equipment.